QUSVM

Qiming U.S. Ventures Management Portfolio holdings

AUM $23.6M
1-Year Est. Return 18.39%
This Quarter Est. Return
1 Year Est. Return
-18.39%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$23.1M
AUM Growth
-$28M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRML icon
1
Tourmaline Bio
TRML
$1.23B
$11.3M 48.83%
741,691
KRRO icon
2
Korro Bio
KRRO
$396M
$6.41M 27.74%
368,085
JSPR icon
3
Jasper Therapeutics
JSPR
$68.4M
$3.99M 17.29%
928,964
HLVX
4
DELISTED
HilleVax
HLVX
$540K 2.34%
372,615
VTYX icon
5
Ventyx Biosciences
VTYX
$280M
$474K 2.05%
412,225
KZR icon
6
Kezar Life Sciences
KZR
$46.6M
$404K 1.75%
82,871